News
The Advanced Technology Partnerships Initiative
FREDERICK, Md., Oct. 13, 2009 — Amplimmune, Inc., has entered into a broad agreement
with the National Cancer Institute (NCI) for further advancement of two Amplimmune
product candidates into therapies for cancer and autoimmune disease.
MORE
FREDERICK, Md., Sept. 29, 2009 — National Cancer Institute contractor SAIC-Frederick,
Inc., a wholly owned subsidiary of Science Applications International Corporation
(NYSE: SAI), and Roche Applied Science, a division of Roche Diagnostics Corporation
(SIX: RO, ROG; OTCQX: RHHBY), have signed a collaboration agreement to assess Roche’s
advanced technologies to sequence the genomes of cancer research samples.
MORE
Frederick, Md., May 13, 2009 — SAIC-Frederick Inc., a wholly owned subsidiary of
Science Applications International Corporation (SAIC) [NYSE: SAI], and Sensor Technologies
Inc. of Shrewsbury, Mass., have signed a collaboration agreement to begin integrated
studies of complex protein interactions involved in cancer and other diseases.
MORE
Frederick, Md., April 22, 2009 — Ceres Nanosciences, LLLP, and National Cancer Institute
contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications
International Corporation (NYSE: SAI), have signed a collaboration agreement to
assess Ceres’ nanotechnology-based system that can isolate scant amounts of substances
in body fluids, with an eye toward developing tools for diagnosing cancer at the
earliest possible stage when treatments are most effective.
MORE
Frederick, Md., March 30, 2009 – Two new nanotechnology concepts will undergo preclinical
characterization as part of the National Cancer Institute (NCI) Advanced Technology
Partnerships Initiative to accelerate the development of new treatments for cancer
patients.
MORE
Nov. 12, 2008 – Ground was broken for an advanced technology research facility aimed
at enabling scientists to more rapidly develop a new generation of highly targeted
treatments for cancer patients. The initial phase of the project, in which the National
Cancer Institute, part of the National Institutes of Health, will be the anchor
tenant, will provide up to 330,000 square feet of space for offices and state-of-the-art
laboratories.
MORE
Oct. 23, 2008 – Two partnership agreements have been signed that inaugurate the
National Cancer Institute’s new Advanced Technology Partnerships Initiative (ATPI),
which seeks to accelerate the delivery of new products to cancer patients.
MORE